Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Progress
Nature Genetics  32, 97 - 105 (2002)
doi:10.1038/ng0902-97


There is an Erratum (October 2002) associated with this Progress.

Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae

Tom H.M. Ottenhoff1, Frank A.W. Verreck1, Elgin G.R. Lichtenauer-Kaligis2, Marieke A. Hoeve1, Ozden Sanal3 & Jaap T. van Dissel2

1  Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.

2  Department of Infectious Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.

3  Immunology Division, Hacettepe University Children's Hospital, Ankara, Turkey.

Correspondence should be addressed to Tom H.M. Ottenhoff T.H.M.Ottenhoff@lumc.nl.
Host genetic factors are important in determining the outcome of infections caused by intracellular pathogens, including mycobacteria and salmonellae, but until now have been poorly characterized. Recently, some individuals with severe infections due to otherwise weakly pathogenic mycobacteria (non-tuberculous mycobacteria or Mycobacterium bovis bacille Calmette-Guérin) or Salmonella species have been shown to be unable to produce or respond to interferon-bold gamma. This inability results from mutations in any of five genes encoding essential proteins of the type 1 cytokine cascade: interleukin-12p40, interleukin-12Rbeta1, interferon-bold gammaR1, interferon-bold gammaR2 or STAT1. Ten syndromes have thus far been identified. Recent insights in genetically controlled host defense and susceptibility to mycobacterial disease are discussed.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Susceptibility to mycobacterial infections: the importance of host genetics
Genes and Immunity Reviews (01 Jan 2003)
The human model: a genetic dissection of immunity to infection in natural conditions
Nature Reviews Immunology Review (01 Jan 2004)
 See all 7 matches for Reviews

NEWS AND VIEWS
Regulation of THI differentiation - controlling the controllers
Nature Immunology News and Views (01 Jun 2002)
Novel interferons
Nature Immunology News and Views (01 Jan 2003)

RESEARCH
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
Nature Genetics Article (01 Apr 1999)
 See all 13 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link
Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy